Analysts think OGN stock price could increase by 34%
Oct 05, 2024, 11:26 AM
-1.20%
What does OGN do
Organon & Co., headquartered in Jersey City, develops innovative health solutions in women’s health, biosimilars, and established brands, employing 10,000 people and operating six manufacturing facilities worldwide. The company went public on May 14, 2021, and offers products like Nexplanon and Follistim AQ through various distribution channels.
10 analysts think OGN stock price will increase by 33.84%. The current median analyst target is $24.48 compared to a current stock price of $18.29. The lowest analysts target is $17.17 and the highest analyst target is $31.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
